Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Aprepitant MeSH Descriptor Data 2026


MeSH Heading
Aprepitant
Tree Number(s)
D03.383.533.640.125
Unique ID
D000077608
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077608
Scope Note
A morpholine neurokinin-1 (NK1) receptor antagonist that is used in the management of nausea and vomiting caused by DRUG THERAPY, and for the prevention of POSTOPERATIVE NAUSEA AND VOMITING.
Entry Term(s)
(1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine
(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine
Emend
L 754,030
L 754030
L-754,030
L-754030
MK 0517
MK 0869
MK 869
MK-0517
MK-0869
MK-869
MK0517
Pharm Action
Antiemetics
Neurokinin-1 Receptor Antagonists
Registry Numbers
1NF15YR6UY
0
CAS Type 1 Name
3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-
Public MeSH Note
2019; APREPITANT was indexed under MORPHOLINES 1998-2018
History Note
2019 (1998)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Aprepitant Preferred
(1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine Narrower
L 754030 Narrower
MK 869 Narrower
Emend Narrower
MK 0517 Narrower
(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine Related
page delivered in 0.146s